U.S. Professional Services Stock News

Earlier this month, CRISPR Therapeutics AG filed a shelf registration for up to US$969.16 million in common shares tied to an ESOP-related offering, while shareholders approved amendments to the company’s articles of association at the June 4, 2026 annual meeting. Against a backdrop of earnings estimate revisions, revenue growth expectations, and a valuation premium versus peers, these capital and governance moves come as investors reassess CRISPR Therapeutics’ long‑term profile and...

MBX Biosciences (MBX) has drawn fresh attention after publishing full Phase 2 Avail and one-year open-label data for its lead candidate canvuparatide in chronic hypoparathyroidism, alongside confirming plans for a pivotal Phase 3 trial. See our latest analysis for MBX Biosciences. Against this backdrop, MBX Biosciences stock has seen strong momentum, with a 7 day share price return of 29.36% and a 90 day share price return of 41.01%, while the 1 year total shareholder return is very large at...

In the past week, EZCORP drew higher trading interest as investors reacted to expectations for upcoming quarterly earnings of US$0.39 per share and projected revenue of US$405 million, both seen higher than the prior year. This shift in sentiment highlights how earnings and revenue forecasts can quickly reshape perceptions of EZCORP’s operating momentum and business trajectory. We’ll now examine how these stronger earnings and revenue expectations could influence EZCORP’s investment...

SiTime (SITM) is back in focus after fresh news on its timing systems for AI and data center uses, combined with expanded enterprise AI deployments and a debate over potential overvaluation. See our latest analysis for SiTime. SiTime's recent AI and data center headlines arrive after a sharp 99.21% 90 day share price return and a 210.40% 1 year total shareholder return. At the same time, the 30 day share price return declined 11.52%, which hints that momentum has cooled in the very short term...

McKesson (MCK) stock is in focus after a cluster of recent moves, including a US$2.25b senior secured term loan maturing in 2032, a minority sale in Medical-Surgical Solutions and ongoing share repurchases. See our latest analysis for McKesson. After a weaker quarter and a pullback that left the 90 day share price return down 14.66% and the year to date share price return down 4.62%, McKesson still has a 1 year total shareholder return of 8.87% and a very large 5 year total shareholder...

The Federal Reserve’s latest meeting is putting interest rates, the US Dollar, and inflation expectations back at the center of portfolio decisions. With markets watching for hawkish hints from Chair Kevin Warsh and the Summary of Economic Projections, currency moves could have a meaningful impact on companies that earn a large share of their revenue in US Dollars. This article highlights three stocks from the US Dollar Beneficiaries screener that appear well placed to be positively exposed...

In mid-June 2026, Jefferies Financial Group Inc. announced several new callable senior unsecured fixed-rate notes maturing between 2031 and 2051, while also completing smaller fixed-income offerings earlier that month at par with modest discounts. At the same time, Jefferies raised its copper price forecasts following an interim US-Iran peace agreement that eased geopolitical tensions and supported expectations for steadier metals demand. We’ll now examine how Jefferies’ higher copper...

In recent days, BTIG named Rithm Capital as its top pick in the U.S. mortgage sector for the second half of 2026, highlighting resilient mortgage demand and an improving operating backdrop despite a more challenging interest-rate setting. At the same time, analyst expectations for flat earnings per share alongside a projected double-digit increase in quarterly revenue suggest that efficiency gains and business mix, rather than headline profit growth alone, are becoming central to how...

Some Madison Square Garden Entertainment Corp. ( NYSE:MSGE ) shareholders may be a little concerned to see that the...

Pentair recently marked its 50th consecutive dividend increase and reported strong Q1 2026 results, including higher profit, revenue growth, and updated adjusted EPS guidance. This combination of a long-running dividend growth record and solid quarterly performance highlights Pentair’s emphasis on consistent shareholder returns backed by operating strength. We’ll now examine how Pentair’s 50-year dividend increase streak may influence its existing investment narrative and future...

With no single headline event driving attention to Stifel Financial (SF), recent price moves and valuation signals are drawing interest instead, as investors reassess the stock’s role within diversified financial holdings. See our latest analysis for Stifel Financial. Recent trading has been choppy for Stifel Financial, with the share price at $74.26 after a 1-day share price return of 1.48% and a 7-day share price return of 4.01%. The year-to-date share price return is down 13.19% against a...

In its latest quarterly report, Renasant posted revenue and earnings above analyst expectations, although net interest income fell short, making the overall performance mixed. This combination of stronger-than-expected top-line results and an earnings beat, despite pressure on net interest income, appears to have improved investor confidence in the bank’s underlying business. With revenue and earnings surpassing analyst expectations, we’ll now examine how this performance may influence...

Earlier this month, Woodward announced that Terence J. Voskuil plans to retire as Executive Vice President and Chief Technology Officer for Aerospace on October 2, 2026, while continuing in his role until that date. At the same time, a peace deal leading to the reopening of the Strait of Hormuz is expected to support airline economics and aircraft demand, reinforcing the importance of Woodward’s aerospace portfolio. We’ll now examine how the Strait of Hormuz reopening, and its potential...

IMAX recently benefited from the global opening of Universal’s “Disclosure Day,” which generated US$93.9 million in box office sales, with the company’s premium screens contributing nearly 15% of that total by offering an enhanced theatrical experience. This performance highlights how IMAX’s immersive technology can capture a disproportionate share of blockbuster ticket sales, potentially reinforcing its role as a preferred format for major film releases. We’ll now examine how IMAX’s strong...

In recent days, Quantum Computing Inc. has drawn heightened attention after analysts highlighted its room-temperature photonic platform, recent Luminar Semiconductor and NuCrypt acquisitions, and stronger quarterly results as key drivers of its expanding role in quantum communications, AI acceleration, and secure networking. An interesting aspect of this development is how the company’s acquisitive build-out of quantum-photonics manufacturing capacity is reshaping its asset base faster than...

When companies post strong earnings, the stock generally performs well, just like Victoria's Secret & Co.'s ( NYSE:VSXY...

Earlier in June 2026, Los Alamos National Laboratory announced a collaboration with MaxLinear to integrate its Panther storage accelerator SoCs into hardware-accelerated OpenZFS for large-scale high-performance computing, targeting higher throughput, lower latency and reduced CPU load for NVMe flash-based storage. The partnership showcases how offloading compression and checksum workloads to Panther hardware can materially boost ZFS performance for high-entropy scientific data while...

If you are wondering whether Jabil stock still offers value after a strong run, this article will walk through what the current price might be implying. The stock last closed at US$375.51, with returns of 3.6% over the past week, 10.5% over the past month, 56.2% year to date and 91.0% over the past year, plus a very large 3 year gain of 256.9% and an even larger 5 year return of about 7x. Recent headlines around Jabil have focused on its role as a major manufacturing partner across...

LyondellBasell Industries (LYB) is back in focus after reporting Q1 2026 earnings of $0.49 per share, a 48% year-over-year increase, and closing the sale of selected European olefins and polyolefins assets to AEQUITA. See our latest analysis for LyondellBasell Industries. LyondellBasell Industries shares closed at $62.59, with the 30 day share price return down 16.61% and the 90 day share price return down 16.77%. At the same time, the 1 year total shareholder return is 13.15%, suggesting...

EchoStar stock reacts to SpaceX spectrum deal and IPO EchoStar (SATS) stock has been swinging sharply after a US$17b spectrum sale to SpaceX tied the company’s fortunes to SpaceX equity. FCC approval has cemented its role as a spectrum monetizer. See our latest analysis for EchoStar. EchoStar’s share price has been volatile over the past year as investors react to each SpaceX headline, with a 12.27% 90 day share price return and a very large 1 year total shareholder return that reflects...

Ball (BALL) stock has recently attracted attention after posting annual revenue of US$13.67b and net income of US$936m. This has prompted investors to reassess how its aluminum packaging business is currently being valued. See our latest analysis for Ball. At a share price of US$58.19, Ball has recorded a 7.40% 7-day share price return and a 5.42% 30-day share price return. The 1-year total shareholder return of 6.74% and the 5-year total shareholder return, which is down 23.93%, indicate...

We'd be surprised if Kontoor Brands, Inc. ( NYSE:KTB ) shareholders haven't noticed that the Executive VP, Jennifer...

Wix.com (NasdaqGS:WIX) has become a focus for investors after high profile integrations with OpenAI's Codex Enterprise and Microsoft 365 Copilot, alongside a newly announced US$2b buyback and solid recent financial results. See our latest analysis for Wix.com. Despite high profile AI partnerships and the US$2b buyback announcement, Wix.com’s recent share price return has been weak, with the stock down 18.52% over 30 days and 55.88% year to date, while the 1 year total shareholder return has...

Recent commentary on Surgery Partners highlights slowing sales volume growth and a more cautious revenue outlook, with high debt levels amplifying the company’s financial risk profile. These pressures suggest Surgery Partners may face a challenging balance between funding growth initiatives and maintaining financial flexibility, potentially affecting how investors view its long-term operating plan. We’ll now examine how concerns about weaker sales trends and elevated leverage may reshape...